Profil
Dr. Dimitris Voliotis, MD, is a Chief Medical Officer at Radiopharm Theranostics Ltd. Dr. Voliotis was previously employed as a Senior Vice President-Clinical Development by Zentalis Pharmaceuticals, Inc., a Chief Development Officer by CureVac AG, a Global Head-Clinical Development Oncology by Eisai, Inc., and a Vice President & Head-Oncology Group by Bayer HealthCare AG.
He received his doctorate degree from Universität zu Köln.
Aktiva positioner av Dimitris Voliotis
| Företag | Position | Start |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2024-08-20 |
Tidigare kända positioner av Dimitris Voliotis
| Företag | Position | Slut |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Företagsledare/Principal | 2023-09-01 |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Företagsledare/Principal | 2020-02-01 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Företagsledare/Principal | 2019-01-01 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Företagsledare/Principal | 2014-09-01 |
Dimitris Voliotiss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
















